Skip Navigation



Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology | Family Medicine
Disease Category: Constipation
Location: United States, FL

Clinical Trial Details


Research Study Summary

Research study for volunteers at least 18 years of age who are currently experiencing symptoms of chronic constipation


This is a research study for chronic idiopathic constipation. Subjects who meet the inclusion criteria will be entered into up to a 9 day treatment period. Patients will either receive the product under study or the marketed equivalent or placebo. Medication will be administered orally twice daily.

Patient Inclusion Criteria:

  • Male and non-pregnant females 18 years of age and older
  • Chronic idiopathic constipation defined as, on average <3 bowel movements per week for the past 6 months
  • Confirmation of chronic constipation by a daily diary during the 14 day lead-in period

  • Pregnancy or breast feeding
  • Documented bowel obstruction
  • Crohn’s disease, ulcerative colitis
  • History of bowel resection
  • Regular use of medications known to cause constipation
  • Unstable hypothyroidism, Parkinson’s disease, multiple sclerosis or spinal cord disorder
  • Any hospitalization for any gastrointestinal or abdominal surgical procedure 3 months prior to dosing

Patient Exclusion Criteria:


Both Male and Female


18 and up

Overall Status


Facility Type



Jessica Elkins Hochstetler RN, CCRC, Director of Clinical Research
Emerald Coast Research Associates
221 East 23rd Street, Suite B
Panama City, FL 32405
Phone: 850-785-6550
Fax: 850-785-6804

View Map

Research Center Information: Emerald Coast Research Associates

CW ID: 178792

Date Last Changed: July 19, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.